Dr Matthew Hind, consultant respiratory physician is a specialist in sleep disorders and adult respiratory medicine.
Dr Matthew Hind completed his postgraduate training in respiratory medicine at the Royal Free, Royal Brompton, Hammersmith, St Mary’s and St George’s hospitals soon after gaining his qualifications in medicine at King’s College London. He then completed a PhD in regenerative biology, discovering that damaged lungs can regenerate in response to a particular molecular signal funded by the Wellcome Trust.
For this work, he received the ‘Young Investigator’ award from the British Thoracic Society and a prestigious European Respiratory Society COPD award for ‘outstanding contribution to COPD research in Europe’.
Dr Matthew Hind specialises in all adult respiratory medicine and sleep disorders and is an integral member of the lung failure team at Royal Brompton Hospital. He specialises in chronic obstructive pulmonary disease (COPD), emphysema, smoking-related lung disease, ventilatory failure, developmental lung defects, continuous positive airway pressure (CPAP) and obstructive sleep apnoea.
The National Institute for Health Research (NIHR) have funded a partnership between Royal Brompton Hospital and Imperial College London on stem cell and regenerative therapies at the advanced lung disease unit, which Dr Hind leads on. He also leads multi-disciplinary medical teams to work on complex clinical cases both in the UK and internationally.
Dr Matthew Hind has established a lung development and regeneration laboratory at the National Heart and Lung Institute (NHLI). The molecular signals that switch on lung repair pathways in order to develop new treatments for patients with lung disease, are being actively researched by Dr Hind and his team. His regenerative biology laboratory integrates molecular, genetic and population data to understand and treat lung disease. He has been recognised with both national and international awards for his scientific work.
Dr Matthew Hind has published many peer reviewed articles on the novel treatments for patients with lung disease, basic science of lung development and regeneration, and clinical respiratory medicine.
Dr Matthew Hind is a clinical examiner for the Royal College of Physicians, an honorary senior lecturer at the National Heart and Lung Institute and at Imperial College London, supervises and examines postgraduate PhD students. At King’s College London he is an honorary research fellow at the Medical Research Council Centre for Developmental Neurobiology.